AntriaBio Announces $13 Million Close Of Private Placement Transaction And Plan To Dose First Patient With AB101 This Month Post author:Sam Post published:July 17, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Cancer Biotech G1 Therapeutics Files for $115 Million IPO April 17, 2017 Teva Announces The Launch Of Generic Vagifem In The United States July 24, 2017 Sangamo Receives Fast Track Designation From The FDA For SB-318 And SB-913 In Vivo Genome Editing Product Candidates For The Treatment Of MPS I And MPS II July 13, 2017
Sangamo Receives Fast Track Designation From The FDA For SB-318 And SB-913 In Vivo Genome Editing Product Candidates For The Treatment Of MPS I And MPS II July 13, 2017